Total
0
Shares
Bee Vectoring Technologies International Inc. - CEO, Ashish Malik
CEO, Ashish Malik
Source: Cambridge House International Inc
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Bee Vectoring Technologies (BEE) has signed a commercial agreement with BIOGARD, a leading bioprotectant company in Europe
  • BVT will develop a biological insecticide solution using BIOGARD’s active substance registration
  • The company’s initial priority will be to target greenhouse crops such as strawberries and peppers in Europe
  • BVT is an agriculture technology company that has developed a natural precision agriculture system that replaces chemical pesticides
  • Shares in Bee Vectoring Technologies International Inc. (BEE) are steady, trading at $0.265 per share

Bee Vectoring Technologies (BEE) has signed a commercial agreement with BIOGARD, a leading bioprotectant company in Europe.

Through the commercial agreement, Bee Vectoring Technologies (BVT) will develop a biological insecticide solution using BIOGARD’s active substance registration.

BIOGARD, a division of CBC (Europe) has developed a microbiological insecticide that has been used for years to control insects such as thrips, whiteflies, and aphids. These insects cause damage to multiple crops including strawberries and peppers, which are among the priority target uses for BVT’s solution.

The BIOGARD insecticide will either be used alongside BVT’s own biological fungicide or as a standalone when some diseases are not present in the crops.

Using BVT’s proprietary bee vectoring platform allows the company to use up to 98 per cent less product per hectare compared to traditional application methods. The product will ensure that active ingredients are delivered directly to crop flowers with no waste.

“BVT is a true innovator in sustainable farming practices and natural pest control,” said Vittorio Veronelli, CEO of CBC (Europe). “BVT and BIOGARD are perfectly aligned in our missions to drive sustainable farming practices, and BIOGARD’s microbiological insecticide will work well in bee vectoring.”

As the bioprotectant market in Europe continues to grow, BVT’s initial priority will be to target greenhouse crops such as strawberries and peppers, which represent 200,000 hectares of crops in Europe.

Ashish Malik, CEO of Bee Vectoring Technologies, commented on the new partnership.

“This deal,” he said, “validates that BVT technology can be used to deliver multiple biocontrol agents and extends our solution beyond disease control to now include insect control as well.”

Mr. Malik added, “This is an exciting opportunity for BVT to add value to growers worldwide, help them implement more sustainable practices, and increase BVT’s share of wallet.”

BVT is an agriculture technology company that has developed a natural precision agriculture system that replaces chemical pesticides.

Shares in Bee Vectoring Technologies International Inc. (BEE) are steady, trading at $0.265 per share as of 9:52 am ET.

More From The Market Herald
Nuvei - CEO, Phillip Fayer

" Nuvei (TSX:NVEI) approved to process sports betting in Connecticut

Nuvei Corporation (NVEI) has been granted an online gaming service provider vendor registration in Connecticut.

" Datametrex (TSXV:DM) launches smartphone health app

Datametrex AI (DM) subsidiary Medi-Call MD has officially launched a closed beta test for its Medi-Call health app.
The Market Herald Video

" Nextech AR (CSE:NTAR) launches 3D Rooms for ecommerce

Nextech AR Solutions (NTAR) has formally launched 3D Rooms, an enhancement to its AR suite for ecommerce.
The Market Herald Video

" Nextech AR (CSE:NTAR) launches “mini-metaverse” in London, England

Evan Gappelberg, CEO of Nextech AR, sat down with Dave Jackson to discuss the launch of its “mini-metaverse” at Harmony at London Wall